Immunohistochemical evaluation of nm23-H1 gene product in transitional cell carcinoma of the bladder

Histopathology

Volumn 28, Issue 5, 1996, Pages 429-435

  Nakopoulou, L L ^a   Constandinides, C A ^a   Tzonou, A ^a   Lazaris, A Ch ^a   Zervas, A ^a   Dimopoulos, C A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

nm23 H1; p53; Survival; Transitional cell carcinoma of bladder

Indexed keywords

PROTEIN P53;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLADDER CARCINOMA; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL; TRANSITIONAL CELL CARCINOMA;

EID: 0029941042     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1996.336375.x     Document Type: Article

References (26)

1. Pitot HC. The molecular biology of carcinogenesis. Cancer Sup. 1993; 72; 962-970.
2. Backer JM, Mendola CE, Kovesdi L et al. Chromosomal localisation and nucleotide diphosphate kinase activity of human metastasis-suppressor genes nm23-H1 and nm23-H2. Oncogene 1993; 8; 497.
3. Tokunaga Y, Urano T, Furukawa K, Kondo H, Kanematsu T, Shiku H. Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer. Int. J. Cancer 1993; 55; 66-71.
4. Wang L, Patel U, Ghosh L, Chen H-C, Banerjee S. Mutation in the nm23 gene is associated with metastasis in colorectal cancer. Cancer Res 1993; 53; 717-720.
5. Leone A, Seeger RC, Hong CM et al. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene 1993; 8; 855-865.
6. Strohmeyer T. Urothelial cancers. Cytogenetic and molecular biology principles. Urologe-A, 1994; 33; 122-127.
7. Nakopoulou L, Zervas A, Zolota V, Filaktopoulos D, Dimopoulos C. Immunohistochemical expression of epidermal growth factor receptor and proto-oncogene c-erbB-2 in transitional cell carcinoma of the bladder. In Olsson CA, ed. Oncogenes and Molecular Genetics of Urological Tumours. London: Churchill Livingstone, 1992; 113-119.
8. Cordon-Cardo C, Dalbagni G, Sacz GT, Oliva MR, Zhang ZF, Rosai J, Reuter VE, Pellicier A. p53 mutations in human bladder cancer: Genotypic versus phenotypic patterns. Int. J. Cancer 1994; 56; 347-353.
9. Williamson MP, Elder PA, Knowles MA. The spectrum of TP53 mutations in bladder carcinoma. Genes Chromosom. Cancer 1994; 9; 108-118.
10. Reuter VE, Melamed MR. The lower urinary tract. In Sternberg SS, ed. Diagnostic Surgical Pathology, Vol. 2, 2nd ed. New York: Raven Press, 1994; 1778-1800.
11. Mostofi FK. International histological classification of tumors. 10, Histological typing of urinary bladder tumors. Geneva: WHO, 1973.
12. Bach BA, Knape WA, Edinger MG, Tubbs RR. Improved sensitivity and resolution in the flow cytometric DNA analysis of human solid tumor specimens. Am. J. Clin. Pathol. 1991; 96; 615-627.
13. Sarkis AS, Dalbagni G, Gordon-Cardo C et al. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J. Natl. Cancer Inst. 1993; 85; 53-59.
14. Igawa M, Rukstalis DB, Tanabe T, Chodak GW. High levels of nm23 expression are related to cell proliferation in human prostate cancer. Cancer Res. 1994; 54; 1313-1318.
15. Hailat N, Keim DR, Melhem RF et al. High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J. Clin. Invest. 1991; 88; 341-345.
16. Radinsky R, Weisberg HZ, Staroselsky AN, Fidler IJ. Expression level of the nm23 gene in clonal populations of metastatic murine and human neoplasms. Cancer Res. 1992; 52; 5808-5814.
17. Nakayama T, Ohtsuru A, Nakao K et al. Expression in human hepatocellular carcinomas of nucleoside diphosphate kinase, a homologue of the nm23 gene product. J. Natl. Cancer Inst. 1992; 84; 1349-1354.
18. Myeroff LL, Markowitz SD. Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential. J. Natl. Cancer Inst. 1993; 85; 147-152.
19. MacDonald NJ, De La Rosa A, Benedict MA, Freijet JMP, Krutsch H, Steeg PS. A serine phosphorylation of nm23 and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J. Biol. Chem. 1993; 268; 25780-25789.
20. Boix L, Bruix J, Campo E et al. nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma. Gastroenterology 1994; 107; 486-491.
21. Florenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS, Podstad O. Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res. 1992; 52; 6088-6091.
22. Leone A, McBride OW, Weston A et al. Somatic allelic deletion of nm23 in human cancer. Cancer Res. 1991; 51; 2490-2493.
23. Brewster SF, Browne S, Brown KW. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma. J. Urol. 1994; 151; 1073-1077.
24. Dati C, Muraca R, Tzartes O. C-erbB-2 and ras expression levels in breast cancer are correlated and show a co-operative association with unfavorable clinical outcome. Int. J. Cancer 1991; 47; 833-838.
25. Barnes R, Masood S, Barker E et al. Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival. Am. J. Pathol. 1991; 139; 245-250.
26. Henessy C, Henry JA, May FEB, Westley BR, Angus B, Lennard TWJ. Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J. Natl. Cancer Inst. 1991; 83; 281-285.